Alta Partners Investment Manager, L.p.

About

Leading Healthcare Venture Capital Firm | Alta Partners About Portfolio Team Feed Connect LP Login Explore Alta Partners About Portfolio Team Feed Connect LP Login Privacy Legal The Latest in Outcomes Lilly to acquire Kelonia Therapeutics to advance in vivo CAR-T cell therapies Kelonia's lead program, KLN-1010, is a potentially first-in-class lentiviral in vivo CAR-T therapy currently in Phase 1 for relapsed/refractory multiple myeloma with clinical data recently highlighted in the 2025 ASH Annual Meeting plenary session Read Press Release The Latest in Outcomes eGenesis Announces Another New Hampshire Man Gets a Pig Kidney as Transplant Trials Are Poised to Start eGenesis Announces Another New Hampshire Man Gets a Pig Kidney as Transplant Trials Are Poised to Start Read Press Release The Latest in Outcomes Tyra Biosciences Announces FDA Orphan Drug Designation for TYRA-300 for the Treatment of Achondroplasia A clinical-stage biotechnology company focused on developing next-generation precision medicines Read Press Release The Latest in Outcomes Variant Bio Turns Toward Discovery of Novel Medicines, Marking a New Chapter of Growth for the Company Variant Bio Turns Toward Discovery of Novel Medicines Read Press Release The Latest in Outcomes Be Biopharma Study Shows First Demonstration of Rapid Engraftment of B Cells without Preconditioning in Non-Human Primates with Intact Immune Systems Be Biopharma Study Shows First Demonstration of Rapid Engraftment of B Cells Read Press R

Key Contact

Geographic Focus